Small Cell Lung Cancer
(SCLC) Treatment
Market
Share, Global Trends,
Analysis, Research, Report,
Opportunities,
Segmentation and Forecast,
2016
Future Market Insights
www.futuremarketinsights.com
[email protected]
Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting
services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,
technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.
We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and
Retail.
We have a global presence with delivery centers across India specializing in providing global research reports and country
research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.
We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for
our client.
Research Capabilities
Sector Coverage








Customized Research
Syndicated Research
Investment Research
Social Media Research
Automotive and Transportation
Electronics, Semiconductor, and ICT
Retail and Consumer Products
Industrial Automation and Equipment
Customized
Research
Subscription Information
Syndicated
Research
For detailed subscription information please contact
Investment
Research
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268
Social Media
Research
Hari. T (Sr. Manager - Global Business Development)
Email: [email protected]




Chemicals & Materials
Food and Beverages
Services and Utilities
Energy, Mining, Oil, and Gas
Report
Description
Report Description
According to the World Health Organization (WHO), 8.2 million people died from cancer
around the world in 2012, and cancer is now one of the leading causes of death. Lung
cancer is the leading cancer type and caused 1.59 million deaths in 2012.
Small cell lung cancer is two types Oat cancer
Combiner small cell cancer
The major risk factors for small cell lung cancer are tobacco, alcohol, unhealthy food and
physical inactivity. Some chronic infections also causes cancer. Having family history of
lung cancer and being effected with the HIV also risk factors for small cell lung cancer
Symptoms of small cell lung cancer include coughing, blood in sputum, wheezing, chest
pain, and shortness of breath. Current treatments are not cure the cancer in some
patients with small cell lung cancer.
To treat small cell lung cancer following treatments are available:
Surgery
Radiation therapy
Chemotherapy
Doctors performed surgery to remove malignant tumor and lymph node.
Report
Description
Report Description
Chemotherapy and radiation therapy given to the patient at a time to treat early stage of
small cell lung cancer. Giving to treatments at a time to the patient is called concurrent
chemo radiation.
Radiation therapy is given to the patient to shrink tumor cells as well as to relieve
symptoms such as bleeding, cough, trouble swallowing and shortness of breath. Threedimensional conformal radiation therapy (3D-CRT) and Intensity modulated radiation
therapy (IMRT) are the two types of radiation methods used in the treatment.
Request free sample Report:
http://www.futuremarketinsights.com/reports/sample/rep-gb-1244
Small Cell Lung Cancer (SCLC) Treatment Market: Drivers and Restraints
According to World Health Organization, cancer is the leading cause of death and it
accounts 8.2 million deaths in 2012. Lung cancer is the leading cancer among the other
cancers. For instance, 1.59 million people died with lung cancer around the world.
Changing life style, smoking, increased alcohol consumption, unhealthy food, air
pollution and no physical activity are indirectly driving the market. International
healthcare organizations such as World Health Organization (WHO), National Cancer
Institute, American Cancer Society also providing guidelines for cancer patients.
Governments in the emerging economies are providing awareness among the people
about the cancer.
Report
Description
Report Description
The above are driving factors for small cell lung cancer market.
Cost of the treatment and lack of awareness among the people for early detection of
cancer are restrains for small cell lung cancer market
Small Cell Lung Cancer (SCLC) TreatmentMarket: Segmentation
Small Cell Lung Cancer (SCLC) Treatment market is segmented into following types
Based on Treatment
Radiation Therapy
Three-dimensional conformal radiation therapy (3D-CRT)
Intensity modulated radiation therapy (IMRT)
Chemotherapy
Platinum derivatives
Topoisomerase Inhibitor
Surgeries
Based on End User
Hospital
Hospital Pharmacies
Report
Description
Report Description
Drug store
Ambulatory Surgical Center
Request for TOC: http://www.futuremarketinsights.com/toc/rep-gb-1244
Small Cell Lung Cancer (SCLC) Treatment Market: Overview
Increasing awareness about cancer among common people and guidance from
international organizations about the small cell lung cancer (SCLC) Treatment, the market
is expected to have a healthy growth in the forecast period (2016-2026)
Small Cell Lung Cancer (SCLC) Treatment Market: Region- wise Outlook
Depending on geographic regions, the global Small Cell Lung Cancer (SCLC) Treatment
market is segmented into seven key regions: North America, South America, Eastern
Europe, Western Europe, Asia Pacific excluding Japan, Japan andMiddle East & Africa.
Small Cell Lung Cancer (SCLC) Treatment is high in North America because it
is highly developed region, having good healthcare setup and people are having good
awareness about health care. Asia Pacific is expected to grow at a remarkable CAGR.
Europe also having good growth in this market.
Browse full report: http://www.futuremarketinsights.com/reports/small-cell-lungcancer-sclc-treatment-market
Report
Description
Report Description
Small Cell Lung Cancer (SCLC) Treatment Market: Key Players
Some of the key players in this market are Teva parenteral medicines inc.,
Bristol myers co, Novartis AG, Elekta AB, Siemens Healthcare GmbH, Bedford
laboratories and App pharmaceuticals llc
Thank You!
To know more about us, please visit our website:
www.futuremarketinsights.com
For sales queries or new topics email us on:
[email protected]
For other queries contact: Mr. Sudip Saha
Future Market Insights: 616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
T: +1-347-918-3531 | D: +1-845-579-5705